Europaudvalget 2023-24
KOM (2023) 0411 Bilag 3
Offentligt
2772950_0001.png
Commission proposal
on plants obtained
by certain new genomic
techniques (NGTs)
The Danish Parliament’s European Affairs Committee
visit
25 October 2023 - Brussels
1
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0002.png
EU Green Deal
EU Climate Law
EU Bioeconomy
Strategy
Open Strategic
Autonomy
Farm to Fork
Food security
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0003.png
Developments leading to the NGT proposal
EU Court of Justice’s judgment
Council Decision
in Case C-528/16
(EU) 2019/1904
Commission study on
NGTs
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0004.png
Objectives of the proposal
High level of protection of health and
environment
Developments to contribute to sustainability
and climate adaptation in a wide range of
plant species, especially for the agri-food
system
Opportunities for research and innovation,
including for SMEs
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0005.png
Evidence
Two 2021 reports
Case studies (2023)
EURL,ENGL (2019, 2023)
Two fact-finding studies
on official controls in
Member States
Impact
Assessment
Opinions on NGTs
Statement on risk
assessment criteria
Targeted interviews
Targeted survey
Focus groups
Desk research
Case studies
Inception
impact
assessment
5
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0006.png
Safety
Variety of different products with different safety profiles.
No specific hazard associated to these techniques.
Similar products obtained by different techniques are not expected to present significantly different risks.
Lesser amounts of risk assessment data on a case-by-case basis.
Potential for reduced unintended effects.
6
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0007.png
Examples of NGT plants – JRC case studies
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0008.png
Subject matter & scope
of…
Deliberate release
into the
environment for any other purpose than
placing on the market (e.g. field trials)
Placing on the market
• Plants obtained by targeted
mutagenesis and cisgenesis, including
intragenesis (‘NGT
plants’)
NGT plants
• NGT
food/feed
Other products
containing/consisting
of NGT plants
8
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0009.png
kom (2023) 0411 - Bilag 3: Præsentationen fra DG SANTE vedr. NGT
2772950_0010.png
Thank you
Useful links:
https://ec.europa.eu/commission/presscorner/detail/en/qanda_23_3568
https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/13119-Legislation-for-
plants-produced-by-certain-new-genomic-techniques
https://food.ec.europa.eu/plants/genetically-modified-organisms/new-techniques-
biotechnology_en
© European Union 2023
Unless otherwise noted the reuse of this presentation is authorised under the
CC BY 4.0
license. For any use or reproduction of elements that are
not owned by the EU, permission may need to be sought directly from the respective right holders.
10